Group Post |
NEW STUDY: Genetic data show how a single superspreading event sent coronavirus across the nation and world |
mike kraft |
Group Post |
Why new cases of the coronavirus are down across most of the U.S. |
mike kraft |
Group Post |
Africa declared free of wild polio in 'milestone' |
mike kraft |
Group Post |
Drugmaker ramping up production of potential coronavirus vaccine in record time |
mike kraft |
Group Post |
American Airlines touts a new tool to combat COVID. But does it really make flying safer? |
mike kraft |
Group Post |
ANALYSIS: We’re not doing enough to protect COVID-19 vaccine research from cyber espionage |
mike kraft |
Group Post |
Young people fueling recent spike of coronavirus in Americas, U.N. agency says |
mike kraft |
Group Post |
Facing 2nd virus wave, Spain tracks infections with soldiers |
mike kraft |
Group Post |
COVID-19: How South Korea Prevailed While the U.S. Failed |
mike kraft |
Group Post |
COVID-19 lockdowns blocked flu in some places but fall looms |
mike kraft |
Group Post |
Flu Season Could Make Coronavirus Testing Delays Even Worse |
mike kraft |
Group Post |
Moderna says its coronavirus vaccine shows promising results in small trial of elderly patients |
mike kraft |
Group Post |
The coronavirus may shut down the immune system’s vital classrooms |
mike kraft |
Group Post |
Covid-19 adds extra headache to Hurricane Laura evacuations |
mike kraft |
Group Post |
Damage from whopper hurricanes rising for many reasons |
mike kraft |
Group Post |
Japanese researchers say ozone effective in neutralising coronavirus |
mike kraft |
Group Post |
FDA authorizes Abbott’s fast $5 COVID-19 test |
mike kraft |
Group Post |
EU pays 336 million euros for doses of AstraZeneca's potential COVID-19 vaccine |
mike kraft |
Group Post |
Maine sleep-away camps prevented coronavirus spread among more than 1,000 people, CDC report finds |
mike kraft |
Group Post |
INNOVATIONS: Japanese firms develop ways to cool facewmasks.p |
mike kraft |
Group Post |
Trump administration to purchase 150 million Abbott COVID-19 tests for $750 million |
mike kraft |
Group Post |
Moderna and Pfizer’s COVID-19 vaccine candidates require ultra-low temperatures, raising questions about storage, distribution |
mike kraft |
Group Post |
In contrast to US, WHO backs testing people without symptoms |
mike kraft |
Group Post |
CDC director clarifies change in coronavirus testing guidelines after backlash |
mike kraft |
Group Post |
New reckoning for WHO vaccine plan as governments go it alone |
mike kraft |
Recent Comments